TBX21 rs11650354: What Your Genotype Means
The rs11650354 variant is a single nucleotide polymorphism located within the TBX21 gene. Research has identified this variant as being associated with an increased risk of developing allergic asthma in children.
What each genotype means
Average risk profile
This is the most common genotype for this variant in the TBX21 gene. Research indicates this genotype is considered the normal or reference state and is not associated with an increased risk of allergic asthma.
This is the most frequently observed genotype across most studied populations.
Possible increased asthma risk
Carrying one copy of the T allele may be associated with a potential increase in the risk of developing allergic asthma. This association is based on studies of childhood asthma, though individual risk is influenced by many genetic and environmental factors.
The frequency of this heterozygous genotype varies significantly depending on ancestral background.
Elevated asthma risk
Research has identified this genotype as being associated with a higher statistical risk for allergic asthma in children compared to those with the C/C genotype. This finding reflects population-level associations and does not mean that an individual will necessarily develop the condition.
This homozygous genotype is less common than the C/C or C/T genotypes in most populations.
Understanding the SNP
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs11650354 is located on chromosome 17 at position 47,744,726 (GRCh38). This specific location sits within the TBX21 gene, which provides instructions for making a protein known as T-bet. Because this SNP is located in a region that influences gene expression or protein function, researchers study it to understand how subtle changes in our genetic code might contribute to complex health traits. It is important to note that having a specific genotype at this location does not guarantee the development of any condition, as asthma is a complex disease influenced by a combination of genetic, environmental, and lifestyle factors.
The Role of the TBX21 Gene
The TBX21 gene encodes the T-box transcription factor T-bet, which plays a critical role in the immune system. T-bet is essential for the development and function of T-helper 1 (TH1) cells, which help the body fight off infections. In the context of allergic diseases, the balance between TH1 and TH2 immune responses is vital. Asthma and allergies are often characterized by an overactive TH2-mediated inflammatory response. By influencing how T-cells mature and respond to signals, variations in TBX21 may potentially shift this immune balance. Scientists have investigated whether these genetic differences contribute to the susceptibility of individuals to allergic inflammation, making TBX21 a significant candidate gene in respiratory and immunological research.
Research and Evidence Strength
The evidence linking rs11650354 to allergic asthma is considered moderate and is primarily derived from studies of childhood populations. One notable study published in the Journal of Allergy and Clinical Immunology observed that children carrying specific alleles at this locus, particularly those with the T;T genotype, showed a significantly higher odds ratio for allergic asthma compared to those with the C;C genotype. While these statistical associations are compelling, they are often specific to certain cohorts and may not be universally applicable across all ancestral backgrounds. Furthermore, asthma is a polygenic trait, meaning it is influenced by many different genes rather than a single variant. Therefore, while rs11650354 is a useful marker in research, it is only one piece of a much larger and more complex genetic puzzle.
Population Frequency
The frequency of the rs11650354 variant varies across different global populations. Genetic databases indicate that the minor allele frequency is approximately 0.1244, though this can fluctuate significantly depending on the ancestral background of the group being studied. Because the prevalence of both the variant and the associated asthma traits can differ by ethnicity and environment, researchers emphasize the importance of considering ancestry when interpreting genetic data. The variability in these frequencies highlights why large-scale, diverse genomic studies are necessary to fully understand the impact of this SNP on a global scale.
What This Information Means for You
If you have received information about your rs11650354 genotype, it is important to view it through the lens of scientific research rather than clinical diagnosis. Genetic associations are statistical observations made across large groups of people and cannot predict individual health outcomes. You cannot use this information to diagnose yourself with asthma or to determine your future health risks. If you have concerns about respiratory health, allergies, or asthma symptoms, the most effective step is to consult with a healthcare professional. They can evaluate your clinical history, perform necessary diagnostic tests, and provide personalized medical advice. Never make changes to your health management or medication based on genetic data without first discussing it with your doctor or a qualified pharmacist.
How common is this variant?
The global minor allele frequency for rs11650354 is approximately 0.1244, though this frequency is variable across different ancestral populations.
Frequently asked questions
Does having the T/T genotype mean I will get asthma?
No, having a specific genotype does not mean you will develop asthma. Asthma is a complex condition influenced by many genes and environmental factors, and genetic markers only indicate statistical associations in large groups.
Can I use this SNP to diagnose asthma?
No, genetic variants like rs11650354 cannot be used for medical diagnosis. A diagnosis of asthma must be made by a healthcare professional based on clinical symptoms, physical exams, and lung function tests.
Is this variant only found in children?
While the primary research linking this variant to allergic asthma was conducted in childhood cohorts, the variant itself exists in the DNA of adults as well. The association is simply most documented in studies focusing on childhood-onset asthma.
Should I change my asthma medication based on this result?
You should never change your medication or treatment plan based on genetic test results. Always discuss your genetic information and any concerns about your treatment with your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11650354?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29